ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 914

When Fibromyalgia Criteria Misclassify

Frederick Wolfe1 and Winfried Häuser2, 1National Data Bank, Wichita, KS, 2Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: diagnosis, Diagnostic criteria and fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Fibromyalgia: Insights Into Diagnostic Criteria and Symptom Epidemiology

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose : The 2010 American College of Rheumatology (ACR) preliminary criteria for the diagnosis of fibromyalgia (FM2010) and its extension for clinical research by patient self-report questionnaire (FM2011) broke with previous 1990 criteria (ACR1990) by eliminating tender points, but also by eliminating the requirement that pain be widespread (4 quadrant + axial) (WSP). By changing the definition of fibromyalgia (FM), the 2010 and 2011 criteria created an expected and natural discordance with the 1990 criteria. In addition, some researchers indicated that elimination of WSP could lead to misclassification by including cases that did not have generalized pain (ACR1990 regions = 5) into the FM definition; and thereby introducing bias favoring psychological symptoms. In the ACR 2010 criteria paper, WSP was absent in 6%-7% of those with FM.

Methods:  From 17,385 mixed rheumatic disease patients, we studied 4,964 (28.6%) who satisfied FM2011 criteria, and we evaluated the presence of WSP, and widespread pain index (WPI) scores (0-19) and the Symptom severity scales (SSS) (0-12). FM is diagnosed when (WPI ≥7 AND SS ≥5) OR (WPI 3–6 AND SS ≥9). We also calculated the number of painful regions (0-5: 4 quadrants + axial) from ACR1990. We determined the proportion of patients meeting FM2011 criteria who did not meet the ACR1990 widespread pain definition

Results: Among patients FM2011 (+) 6.6% did not have WSP. 3.5% those FM2011 (+) who had WPI <7did not have WSP.  As shown in Table 1, 93.4% of FM2011 (+) had 5 ACR1990 painful regions; 5,3% had 4, and only 1.3% had <4. For the 0-19 WPI, 7% had scores between 4 and 6. Overall, those not meeting the ACR1990 definition, and those perhaps appropriately (regions = 4) not meeting the criteria, were few. 

Conclusion:   FM criteria may be used 1) for differential diagnosis in which fibromyalgia is the best clinical diagnosis to explain a patient’s symptoms; or 2) for concomitant diagnosis in which the several illness are identified, one of which is fibromyalgia. FM2010 and FM2011 were designed for optimal diagnosis in the setting of usual rheumatic disease presentation and usual clinic prevalence. When used in settings where non-WSP and regional or psychiatric diagnoses are substantially increased, FM criteria will “misclassify” persons. This occurs because there is no reliable gold standard fibromyalgia definition. The solution to this type of misclassification is to use the most appropriate clinical diagnosis (e.g., regional arm pain or rheumatoid arthritis) and indicate the patient also satisfied fibromyalgia criteria. In a general or rheumatic disease clinic setting few people will meet FM2011 criteria without WSP, but most will also have many painful regions.

Table 1. Relation between Widespread Pain index and Widespread Pain Regions (ACR1990) and Fibromyalgia Criteria Status

 

Widespread Pain Index (WPI)

FM2011 (-)

FM2011 (+)

Widespread Pain Regions

FM2011 (-)

FM2011 (+)

0

2,157

0

0

2,256

0

%

17.4

0

%

18.2

0

1

1,691

0

1

0

0

%

13.6

0

%

0

0

2

1,726

0

2

1,942

4

%

13.9

0

%

15.6

0.1

3

1,610

77

3

1,839

61

%

13.0

1.6

%

14.8

1.2

4

1,421

76

4

2,468

262

%

11.4

1.5

%

19.9

5.3

5

1,199

89

5

3,916

4,637

%

9.7

1.8

%

31.5

93.4

6

996

105

 

 

 

%

8.0

2.1

 

 

 


Disclosure: F. Wolfe, None; W. Häuser, None.

To cite this abstract in AMA style:

Wolfe F, Häuser W. When Fibromyalgia Criteria Misclassify [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/when-fibromyalgia-criteria-misclassify/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/when-fibromyalgia-criteria-misclassify/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology